ID   UCK1_HUMAN              Reviewed;         277 AA.
AC   Q9HA47; Q5JT09; Q5JT10; Q5JT12; Q5JT13; Q6IA74; Q96BJ0;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   12-APR-2017, entry version 139.
DE   RecName: Full=Uridine-cytidine kinase 1;
DE            Short=UCK 1;
DE            EC=2.7.1.48;
DE   AltName: Full=Cytidine monophosphokinase 1;
DE   AltName: Full=Uridine monophosphokinase 1;
GN   Name=UCK1; Synonyms=URK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHARACTERIZATION.
RX   PubMed=11306702;
RA   Van Rompay A.R., Norda A., Linden K., Johansson M., Karlsson A.;
RT   "Phosphorylation of uridine and cytidine nucleoside analogs by two
RT   human uridine-cytidine kinases.";
RL   Mol. Pharmacol. 59:1181-1186(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Ho Y.S., Johnson R.K.;
RT   "Human uridine kinase from prostate cancer cell line (LNCaP).";
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Xin Y.R., Yu L., Zhao S.Y.;
RT   "Cloning of a new human cDNA similar to Mus musculus uridine kinase
RT   mRNA.";
RL   Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Hippocampus, and Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-251 AND SER-253, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-253, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 22-243 IN COMPLEX WITH ADP.
RG   Northeast structural genomics consortium (NESG);
RT   "Structure of human uridine-cytidine kinase 1.";
RL   Submitted (JAN-2007) to the PDB data bank.
CC   -!- FUNCTION: Phosphorylates uridine and cytidine to uridine
CC       monophosphate and cytidine monophosphate. Does not phosphorylate
CC       deoxyribonucleosides or purine ribonucleosides. Can use ATP or GTP
CC       as a phosphate donor. Can also phosphorylate cytidine and uridine
CC       nucleoside analogs such as 6-azauridine, 5-fluorouridine, 4-
CC       thiouridine, 5-bromouridine, N(4)-acetylcytidine, N(4)-
CC       benzoylcytidine, 5-fluorocytidine, 2-thiocytidine, 5-
CC       methylcytidine, and N(4)-anisoylcytidine.
CC   -!- CATALYTIC ACTIVITY: ATP + uridine = ADP + UMP.
CC   -!- CATALYTIC ACTIVITY: ATP + cytidine = ADP + CMP.
CC   -!- PATHWAY: Pyrimidine metabolism; CTP biosynthesis via salvage
CC       pathway; CTP from cytidine: step 1/3.
CC   -!- PATHWAY: Pyrimidine metabolism; UMP biosynthesis via salvage
CC       pathway; UMP from uridine: step 1/1.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9HA47-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HA47-2; Sequence=VSP_041269;
CC         Note=Ref.8 (AAH15547) sequence is in conflict in position:
CC         180:A->T. {ECO:0000305};
CC       Name=3;
CC         IsoId=Q9HA47-3; Sequence=VSP_045174;
CC       Name=4;
CC         IsoId=Q9HA47-4; Sequence=VSP_056748;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- SIMILARITY: Belongs to the uridine kinase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF237290; AAK28324.1; -; mRNA.
DR   EMBL; AF254133; AAK49122.1; -; mRNA.
DR   EMBL; AF125106; AAL75943.1; -; mRNA.
DR   EMBL; AK022317; BAB14010.1; -; mRNA.
DR   EMBL; AK295471; BAG58400.1; -; mRNA.
DR   EMBL; CR457281; CAG33562.1; -; mRNA.
DR   EMBL; AL358781; CAI40228.1; -; Genomic_DNA.
DR   EMBL; AL358781; CAI40229.1; -; Genomic_DNA.
DR   EMBL; AL358781; CAI40231.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW87983.1; -; Genomic_DNA.
DR   EMBL; BC015547; AAH15547.1; -; mRNA.
DR   EMBL; BC091495; AAH91495.1; -; mRNA.
DR   CCDS; CCDS48046.1; -. [Q9HA47-2]
DR   CCDS; CCDS59151.1; -. [Q9HA47-3]
DR   CCDS; CCDS59152.1; -. [Q9HA47-4]
DR   CCDS; CCDS6944.1; -. [Q9HA47-1]
DR   RefSeq; NP_001129426.1; NM_001135954.2. [Q9HA47-2]
DR   RefSeq; NP_001248379.1; NM_001261450.2. [Q9HA47-3]
DR   RefSeq; NP_001248380.1; NM_001261451.2. [Q9HA47-4]
DR   RefSeq; NP_001305448.1; NM_001318519.1.
DR   RefSeq; NP_113620.1; NM_031432.3. [Q9HA47-1]
DR   UniGene; Hs.9597; -.
DR   PDB; 2JEO; X-ray; 2.50 A; A=22-243.
DR   PDB; 2UVQ; X-ray; 3.00 A; A=22-243.
DR   PDBsum; 2JEO; -.
DR   PDBsum; 2UVQ; -.
DR   ProteinModelPortal; Q9HA47; -.
DR   SMR; Q9HA47; -.
DR   BioGrid; 123681; 7.
DR   IntAct; Q9HA47; 2.
DR   MINT; MINT-1392002; -.
DR   STRING; 9606.ENSP00000361289; -.
DR   ChEMBL; CHEMBL5682; -.
DR   iPTMnet; Q9HA47; -.
DR   PhosphoSitePlus; Q9HA47; -.
DR   BioMuta; UCK1; -.
DR   DMDM; 20455360; -.
DR   EPD; Q9HA47; -.
DR   MaxQB; Q9HA47; -.
DR   PaxDb; Q9HA47; -.
DR   PeptideAtlas; Q9HA47; -.
DR   PRIDE; Q9HA47; -.
DR   DNASU; 83549; -.
DR   Ensembl; ENST00000372208; ENSP00000361282; ENSG00000130717. [Q9HA47-2]
DR   Ensembl; ENST00000372210; ENSP00000361284; ENSG00000130717. [Q9HA47-3]
DR   Ensembl; ENST00000372211; ENSP00000361285; ENSG00000130717. [Q9HA47-4]
DR   Ensembl; ENST00000372215; ENSP00000361289; ENSG00000130717. [Q9HA47-1]
DR   GeneID; 83549; -.
DR   KEGG; hsa:83549; -.
DR   UCSC; uc004cay.4; human. [Q9HA47-1]
DR   CTD; 83549; -.
DR   DisGeNET; 83549; -.
DR   GeneCards; UCK1; -.
DR   HGNC; HGNC:14859; UCK1.
DR   HPA; HPA050969; -.
DR   MIM; 609328; gene.
DR   neXtProt; NX_Q9HA47; -.
DR   OpenTargets; ENSG00000130717; -.
DR   PharmGKB; PA134861770; -.
DR   eggNOG; ENOG410IMEH; Eukaryota.
DR   eggNOG; COG0572; LUCA.
DR   GeneTree; ENSGT00390000015696; -.
DR   HOGENOM; HOG000262756; -.
DR   HOVERGEN; HBG023339; -.
DR   InParanoid; Q9HA47; -.
DR   KO; K00876; -.
DR   OMA; IEQPVYS; -.
DR   OrthoDB; EOG091G07OR; -.
DR   PhylomeDB; Q9HA47; -.
DR   TreeFam; TF316686; -.
DR   BioCyc; MetaCyc:HS05429-MONOMER; -.
DR   BRENDA; 2.7.1.48; 2681.
DR   Reactome; R-HSA-73614; Pyrimidine salvage reactions.
DR   SABIO-RK; Q9HA47; -.
DR   UniPathway; UPA00574; UER00637.
DR   UniPathway; UPA00579; UER00640.
DR   ChiTaRS; UCK1; human.
DR   EvolutionaryTrace; Q9HA47; -.
DR   GenomeRNAi; 83549; -.
DR   PRO; PR:Q9HA47; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000130717; -.
DR   CleanEx; HS_UCK1; -.
DR   ExpressionAtlas; Q9HA47; baseline and differential.
DR   Genevisible; Q9HA47; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019206; F:nucleoside kinase activity; EXP:Reactome.
DR   GO; GO:0004849; F:uridine kinase activity; IBA:GO_Central.
DR   GO; GO:0044211; P:CTP salvage; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006206; P:pyrimidine nucleobase metabolic process; IBA:GO_Central.
DR   GO; GO:0043097; P:pyrimidine nucleoside salvage; IBA:GO_Central.
DR   GO; GO:0044206; P:UMP salvage; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR006083; PRK/URK.
DR   InterPro; IPR029920; UCK-1.
DR   InterPro; IPR000764; Uridine_kinase-like.
DR   PANTHER; PTHR10285:SF92; PTHR10285:SF92; 1.
DR   Pfam; PF00485; PRK; 1.
DR   PRINTS; PR00988; URIDINKINASE.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00235; udk; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Transferase.
FT   CHAIN         1    277       Uridine-cytidine kinase 1.
FT                                /FTId=PRO_0000164453.
FT   NP_BIND      30     38       ATP.
FT   BINDING      87     87       Substrate. {ECO:0000250}.
FT   BINDING     115    115       Substrate. {ECO:0000250}.
FT   BINDING     120    120       Substrate. {ECO:0000250}.
FT   BINDING     169    169       Substrate. {ECO:0000250}.
FT   BINDING     178    178       Substrate. {ECO:0000250}.
FT   BINDING     186    186       Substrate. {ECO:0000250}.
FT   BINDING     215    215       ATP.
FT   MOD_RES     251    251       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     253    253       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ      28     36       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045174.
FT   VAR_SEQ      28     36       VSGGTASGK -> DERFQAGIPLLCLQ (in isoform
FT                                4). {ECO:0000305}.
FT                                /FTId=VSP_056748.
FT   VAR_SEQ     170    277       VLRDVRRGRDLEQILTQYTTFVKPAFEEFCLPTKKYADVII
FT                                PRGVDNMVAINLIVQHIQDILNGDICKWHRGGSNGRSYKRT
FT                                FSEPGDHPGMLTSGKRSHLESSSRPH -> DKEVCRCDHPA
FT                                RSGQYGCHQPDRAAHPGHSEW (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_041269.
FT   CONFLICT      8     17       DCESPAPEAD -> GARARAGAN (in Ref. 3;
FT                                AAL75943). {ECO:0000305}.
FT   CONFLICT     56     57       QR -> HG (in Ref. 3; AAL75943).
FT                                {ECO:0000305}.
FT   CONFLICT    175    175       R -> H (in Ref. 5; CAG33562).
FT                                {ECO:0000305}.
FT   CONFLICT    247    247       S -> T (in Ref. 3; AAL75943).
FT                                {ECO:0000305}.
FT   STRAND       23     29       {ECO:0000244|PDB:2JEO}.
FT   HELIX        36     46       {ECO:0000244|PDB:2JEO}.
FT   HELIX        49     51       {ECO:0000244|PDB:2JEO}.
FT   HELIX        54     56       {ECO:0000244|PDB:2JEO}.
FT   STRAND       58     63       {ECO:0000244|PDB:2JEO}.
FT   HELIX        64     67       {ECO:0000244|PDB:2JEO}.
FT   HELIX        73     80       {ECO:0000244|PDB:2JEO}.
FT   HELIX        89     91       {ECO:0000244|PDB:2JEO}.
FT   HELIX        94    105       {ECO:0000244|PDB:2JEO}.
FT   STRAND      110    112       {ECO:0000244|PDB:2JEO}.
FT   TURN        117    120       {ECO:0000244|PDB:2JEO}.
FT   STRAND      127    129       {ECO:0000244|PDB:2JEO}.
FT   STRAND      133    138       {ECO:0000244|PDB:2JEO}.
FT   TURN        140    143       {ECO:0000244|PDB:2JEO}.
FT   HELIX       146    149       {ECO:0000244|PDB:2JEO}.
FT   STRAND      153    159       {ECO:0000244|PDB:2JEO}.
FT   HELIX       162    173       {ECO:0000244|PDB:2JEO}.
FT   HELIX       180    189       {ECO:0000244|PDB:2JEO}.
FT   HELIX       191    198       {ECO:0000244|PDB:2JEO}.
FT   HELIX       200    205       {ECO:0000244|PDB:2JEO}.
FT   STRAND      207    213       {ECO:0000244|PDB:2JEO}.
FT   HELIX       217    232       {ECO:0000244|PDB:2JEO}.
SQ   SEQUENCE   277 AA;  31435 MW;  AFD9ED92780CD502 CRC64;
     MASAGGEDCE SPAPEADRPH QRPFLIGVSG GTASGKSTVC EKIMELLGQN EVEQRQRKVV
     ILSQDRFYKV LTAEQKAKAL KGQYNFDHPD AFDNDLMHRT LKNIVEGKTV EVPTYDFVTH
     SRLPETTVVY PADVVLFEGI LVFYSQEIRD MFHLRLFVDT DSDVRLSRRV LRDVRRGRDL
     EQILTQYTTF VKPAFEEFCL PTKKYADVII PRGVDNMVAI NLIVQHIQDI LNGDICKWHR
     GGSNGRSYKR TFSEPGDHPG MLTSGKRSHL ESSSRPH
//
